CAR-T therapy pulmonary adverse event profile: a pharmacovigilance study based on FAERS database (2017-2023)

BackgroundChimeric antigen receptor T-cell (CAR-T) therapy, a rapidly emerging treatment for cancer that has gained momentum since its approval by the FDA in 2017, involves the genetic engineering of patients' T cells to target tumors. Although significant therapeutic benefits have been observe...

Full description

Saved in:
Bibliographic Details
Main Authors: Jing Shi (Author), Xinya Liu (Author), Yun Jiang (Author), Mengjiao Gao (Author), Jian Yu (Author), Yuanming Zhang (Author), Li Wu (Author)
Format: Book
Published: Frontiers Media S.A., 2024-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available